Building an M&A pipeline and thesis

# Building an M&A pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → and thesis

When Danaher's corporate development team walks into a target company, they have often been tracking that asset for three to five years. They know the founder's succession timeline, the customer concentration, the second-order competitors, and the price at which the deal creates value versus destroys it, all before a banker ever calls. Contrast this with the acquirer who receives a confidential information memorandum on Tuesday, mobilizes a deal team by Friday, and is bidding in a competitive auction within three weeks. Both companies "do M&A." Only one is building an enterprise.

The distinction is not sophistication of financial modeling. Both can run an accretion/dilution analysis. The distinction is whether the thesis precedes the target or the target manufactures the thesis. Reactive acquirers reverse-engineer a strategic rationale to justify a deal already in motion, and the CFO becomes the person asked to bless a number rather than the person who set the discipline. This lesson is about inverting that dynamic.

From deal sourcing to thesis-driven sourcing

Most M&A destroys value not because the integration failed but because the wrong asset was pursued at the wrong price for a reason that sounded good in a board deck. The antidote is a written, specific, falsifiable investment thesis that governs sourcing *before* any single company is named.

A weak thesis says: "We want to expand into adjacent markets and add scale." That is unfalsifiable, it can justify almost any acquisition. A disciplined thesis is specific enough to *reject* deals. Consider the structure of a strong thesis statement:

> "We will acquire recurring-revenue software businesses serving mid-market logistics operators, at $50-150M enterprise value, where we can cross-sell our existing payments product into their installed base and lift net revenue retentionnet revenue retentionNet Revenue Retention measures the percentage of recurring revenue retained and grown from existing customers over a period, including upsell and expansion, net of downgrades and churn.View full definition → from ~100% to ~115% within 24 months. We win these deals because we are the natural strategic buyer, our distribution is the synergy no financial sponsor can replicate."

Notice what this does. It defines the where to play (segment, size, business model), the source of advantage (why *we* create value others cannot), and the value-creation mechanism (the specific operational lever, quantified). A thesis this precise tells your corporate development team which 40 companies to track and, more importantly, which 400 to ignore.

The three tests every thesis must pass

Before a thesis earns pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → resources, the CFO should force it through three gates:

1. The "why us" test. If a financial sponsor with cheaper capital would pay more than you, you have no business owning this asset, you will lose the auction or win the winner's curse. Your thesis must rest on a synergy or capability *unique to your platform*. Danaher's entire model is built on this: the Danaher Business System is the value-creation engine that justifies a control premium a PE firm cannot underwrite.

2. The "value-creation ownership" test. Every dollar of synergy in the thesis must have a named executive accountable for delivering it, with a timeline. Synergies that live only in the deal model are fiction. If no one in the operating business will sign up to own the cross-sell number, it does not belong in your valuation.

3. The "walk-away price" test. The thesis must specify the price above which value transfers entirely to the seller. This number is set *before* the target has a face and a story, because that is the only moment you can compute it without the anchoring bias that infects live negotiations.

The CFO's role here is not to build the thesis alone, strategy and the business units own the "where to play." The CFO owns the *discipline of the thesis*: insisting it be specific, falsifiable, and priced. You are the person who says, "This thesis could justify buying anyone; sharpen it or we don't fund a pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → around it."

Constructing the pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → as a managed asset

A pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → is not a spreadsheet of companies someone once mentioned. It is a managed portfolio of relationships and intelligence with a deliberate structure. Think of it in three tiers.

Tier 1, Active targets (5-15 companies). These are named assets that fit the thesis precisely, where you maintain a live relationship with ownership, and where you could move within 90 days. For each, you maintain a one-page thesis: fit rationale, estimated value with and without synergies, walk-away price, known risks, and relationship status.

Tier 2, Cultivation (20-50 companies). These fit the thesis but are not yet actionable, the founder isn't ready to sell, the asset needs to mature, or the valuation is irrational. Here the work is patient relationship-building: attending the same conferences, occasional CEO-to-CEO contact, tracking financing events and leadership changes that signal a timing shift.

Tier 3, Landscape (the full market map). The comprehensive mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition → of the segment, every player, their ownership, their trajectory. This is your early-warning system. When a Tier 3 company raises a down round or loses its second co-founder, it may become a Tier 2 cultivation target overnight.

Where the intelligence comes from

The reactive acquirer's information source is inboundinboundA strategy that attracts prospects organically via valuable content (blog, SEO, social) rather than interrupting them.View full definition → bankers. The proactive acquirer has a wider aperture:

• The operating businesses themselves. Your division heads compete against, sell alongside, and lose deals to these targets daily. They know which competitor is struggling before it shows up in any data room. This is your single richest source, and most companies fail to harvest it systematically. Build a quarterly cadence where BU leaders surface "companies we wish we owned."
• Advisor relationships kept warm year-round, not activated only when a deal appears. Bankers bring you proprietary looks when they believe you are a serious, fast, credible closer, reputation earned across deals, including the ones you walked away from cleanly.
• Systematic market monitoring, funding rounds, patent filings, executive departures, customer-win announcements, that flags the timing signals that turn a Tier 2 name into a Tier 1 conversation.

The CFO ensures this pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → is *governed like an asset*, not left to episodic enthusiasm. That means a standing corporate development review, quarterly at minimum, where each Tier 1 target's thesis is re-tested against current data. Has the walk-away price moved because the target's end-market deteriorated? Has a competitor's acquisition eliminated the synergy? A pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → that is not re-underwritten is just a graveyard of last year's assumptions.

The CFO as value-discipline anchor

Here is the uncomfortable dynamic every CFO must manage: in a live deal, the organizational gravity pulls toward closing. The corporate development team's success is measured in deals done. The business unit sponsor has emotionally committed. The CEO has told the board a deal is coming. Bankers earn fees only on close. Everyone in the room is, structurally, a *buyer*. You are frequently the only person in the room whose credibility is enhanced by walking away from a bad price.

This is why the discipline must be built into the *process*, not left to your willpower in the moment. Willpower loses to deal momentum every time. Three mechanisms institutionalize the discipline:

Pre-committed walk-away prices. The walk-away number is set during pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → construction, documented, and reviewed by the deal committee *before* negotiations begin. When the auction pushes past it, the conversation is not "should we stretch?", it is "what changed in the thesis to justify revising a number we set with clear eyes?" This reframes escalation from an emotional decision to an analytical one.

Separating the thesis author from the deal underwriter. The person championing the strategic logic should not be the person stress-testing the numbers. A dedicated deal-underwriting function, reporting through finance, independently validates synergy estimates against comparable realized synergies, not aspirational ones. If your model assumes 115% net revenue retentionnet revenue retentionNet Revenue Retention measures the percentage of recurring revenue retained and grown from existing customers over a period, including upsell and expansion, net of downgrades and churn.View full definition →, the underwriter asks: when have we ever delivered that? What did integrations of similar targets actually produce?

A synergy discount curve. Sophisticated acquirers do not put full synergies in the offer price. They know cost synergies are ~70-80% deliverable and revenue synergies are ~30-50% deliverable, based on their own realized track record. The CFO's job is to ensure the *price paid* reflects synergy value the seller helped create only to the extent you are confident of capturing it, and that the aspirational upside stays as *your* return, not something you hand to the seller as a premium.

The reason all of this matters is that the pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → is what makes discipline *affordable*. When you have fifteen actionable Tier 1 targets, walking away from one that got too expensive is easy, there are fourteen others. The reactive acquirer, holding a single live deal, faces a binary choice: this deal or no deal this year. Scarcity destroys discipline. A well-stocked pipeline is not just a sourcing tool; it is the structural foundation of price discipline. This is the argument the CFO makes to the board to justify investing in corporate development capability even in years without a closed transaction.

Turning the thesis into a live deal

The transition from pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition → to executed deal is where thesis discipline either holds or evaporates. Three practices preserve it.

Underwrite to the thesis, not to the auction. When a Tier 1 target becomes available, you already have a thesis and a walk-away price. The temptation in a competitive process is to re-underwrite *upward* to win. Resist by anchoring every valuation revision to a *change in the underlying business*, not a change in competitive intensity. Competitors bidding more is information about their thesis, not yours, and it may mean they are wrong, not that you are.

Sequence diligence around thesis-critical assumptions first. Do not run generic diligence. Your thesis rests on two or three load-bearing assumptions, say, the cross-sell rate and customer retention. Front-load diligence to test *those* first. If the load-bearing assumption breaks, you kill the deal in week two having spent minimal cost, rather than in week ten having burned advisory fees and organizational credibility. The CFO should insist diligence scope be explicitly mapped to the thesis's value drivers.

Pre-wire the integration ownership. Before signing, the executive who will own each synergy signs up to the number and the timeline in writing. This does two things: it converts model assumptions into accountable commitments, and it surfaces skepticism *before* you pay. If the head of the payments business won't commit to the cross-sell number that justifies 40% of your synergy value, you have just learned the deal is overpriced, for free.

The through-line across all of these is that a thesis-driven acquirer treats the deal as the *confirmation* of a long-held view, not the origination of one. By the time you are in the room, the intellectual work is done. Diligence tests the thesis; it does not build it. Negotiation defends your walk-away price; it does not discover it.

Key Takeaways

• Write the thesis before you name the target. A disciplined thesis is specific enough to *reject* most deals, it names the segment, the source of your unique advantage ("why us"), the quantified value-creation lever, and the walk-away price. If a thesis could justify any acquisition, it is not a thesis.

• Manage the pipeline as a three-tier asset with quarterly re-underwriting. Active targets, cultivation targets, and the full landscape mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition →. Harvest your operating businesses as the richest source of proprietary intelligence, your division heads know which competitors are weakening before any banker does.

• A stocked pipeline is the structural foundation of price discipline. With fifteen actionable targets, walking away is easy. Make the case to your board that corporate development capability creates value even in years with no closed deal.

• Institutionalize discipline into the process, because willpower loses to deal momentum. Pre-commit walk-away prices, separate the thesis author from the deal underwriter, and apply a synergy discount curve grounded in your *realized* track record, not aspirations.

• Pre-wire integration accountability before signing. Every synergy dollar needs a named owner who commits in writing. If no operator will sign up for the number, it does not belong in your price.